Cronos (CRON) Revenue Growth (1y) (2019 - 2026)
Cronos (CRON) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -0.81% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -0.24% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.92% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 4.88% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 39.49% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 10.23% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | 59.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.53% |
| Mar 31, 2026 | 369.18% |
| Dec 31, 2025 | 1,572.59% |
| Sep 30, 2025 | 296.01% |
| Jun 30, 2025 | -72.08% |
| Mar 31, 2025 | -61.89% |
| Dec 31, 2024 | -112.64% |
| Sep 30, 2024 | -50.30% |
| Jun 30, 2024 | 49.93% |
| Mar 31, 2024 | 258.24% |
| Dec 31, 2023 | 156.72% |
| Sep 30, 2023 | 21.56% |
| Jun 30, 2023 | -4.79% |
| Mar 31, 2023 | -71.80% |
| Dec 31, 2022 | -751.79% |
| Sep 30, 2022 | 387.90% |
| Jun 30, 2022 | 73.44% |
| Mar 31, 2022 | 98.50% |
| Dec 31, 2021 | -47.50% |
| Sep 30, 2021 | -63.17% |